
Two ASE 2024 Education Opportunities Still Available

Submit ASE 2025 Session Proposals
- Session title
- Two co-chairs with alternates
- Speakers with alternates
- Presentation titles
- Presentation formats
Read the June Echo Magazine

- Reflections on the Past Year as Your ASE President: Truly Another Unforgettable Journey, page 4
- Sonographer Volunteer of the Month-June, Congratulations Karen Zimmerman, BS, ACS, RDCS (AE, PE), RVT, FASE, page 6
- Case Competition Sponsored by the ASE Cardio-Oncology Specialty Interest Group (SIG), page 8
- The Role of Interventional Echocardiographers in Pediatric Cardiology: It All Started with the Babies!, page 9
- A Conversation with Dr. Tal Geva—Reflections on Serendipity, Opportunities, and Excellence, page 13
- ASE Leadership Academy Cohort 3 Graduates Encouraging Leaders of Tomorrow to Apply for Cohort 4, page 19
- In Memory of Arthur E. Weyman, MD, FASE, page 24
Register for the 2024 ASCeXAM Review Course Live Question & Answer Sessions This Saturday!

ASE 2024 Highlights

- 2024 Arthur E. Weyman Young Investigator’s Award Competition Winner, Robert McRae, MD, Seattle Children’s Hospital, Seattle, Washington.
- 2024 Brian Haluska Sonographer Research Award Competition Winner, Babitha Thampinathan, CRCS, RDCS, FASE, Mohawk-McMaster University, Hamilton, Ontario, Canada.
In Memory of Arthur E. Weyman, MD, FASE
It is with great sadness that we inform you that Arthur (Ned) E. Weyman, MD, FASE, passed away on June 17, 2024. Dr. Weyman was ASE’s first secretary of the Board of Directors and subsequently served as the 8th President of ASE serving from January 1991 through June 1993. As one of the founding leaders in echocardiography, he advocated tirelessly for international recognition of the pivotal role the noninvasive assessment tool plays in saving lives by quickly detecting cardiac issues in patients from infants to adults. His presence at the helm of ASE and NBE changed the field forever. He will be missed, and we are forever grateful for his service. Read more about his service and legacy.
Catch The Wave of June CASE
The latest issue of CASE is now available with intriguing reports, including “The Complex Hemodynamic Interplay between Mitral Arcade, Midventricular Obstruction, and Prosthetic Aortic Valve” by Taverna et al. CASE Editor-in-Chief Vincent Sorrell, MD, FASE, remarked, “One of the great values of CASE is the ability to use high-quality echo images matched to tomographic cardiovascular imaging to educate readers about rare diseases they are unlikely to see in their individual clinical practice. This month’s issue fulfills that goal with the report from Taverna that showcases mitral arcade; there are not very many published reports in adults owing to both its rarity and possible under-diagnosis. During the editorial review process, these authors worked closely with section editors who are experts in congenital heart disease to provide readers with very precise descriptions, concluding that this patient likely met criteria for a partial Shone’s complex. They also use very detailed volume-rendered 3D-CT images to demonstrate how the pathoanatomy of this particular mitral arcade is atypical and consists of a double-bridge connecting the anterior and posterior leaflets to the papillary muscles. In summary, the authors rightly conclude that a comprehensive multimodal cardiac imaging approach (CT for anatomy; echo Doppler for physiology) is essential!”
Following that Multimodality Imaging report, authors in Infections in the Heart present a report titled, “Vegetations Lurking in the Dark and the Role of Neoendothelialization,” reviewing the published literature on this potential complication and discussing the possible risk-assessment role of cardiac CT by monitoring neoendothelization in these devices. Over in the Hemodynamic Corner of CASE, there are two reports: one on the importance of spectral Doppler in detecting mitral regurgitation in patients with acoustic shadowing from prosthetic valves, and one that describes the unique mitral and tricuspid spectral Doppler inflow patterns in a patient with non-sinus rhythm. With high-quality 2D and 3D echo images, a case in Rare But Deadly Findings offers a learning lesson to readers about a left atrial dissection after complications of mitral valve surgery. To round out this issue, there is a letter to the editor discussing a previous CASE on a novel transcatheter approach to treat primum atrial septal defects with a response from that article’s authors.
As with all CASE issues, these reports demonstrate the value of quality imaging over quantity. Be sure to read Dr. Sorrell’s editorial as he explores how to maintain this principle in a healthcare environment that increasingly rewards growth and productivity.
Looking for a journal to submit your case report to? We want to hear from you! Email us with questions or submit your report today.
Arthur Weyman ASE’s 8th President Passed Away
It is with great sadness that we write to inform our members that Arthur (Ned) E. Weyman, MD, FASE, passed away this morning, June 17, 2024. Dr. Weyman was ASE’s first secretary of the Board of Directors and subsequently served as the 8th President of ASE serving from January 1991 through June 1993. He received a 2001 American College of Cardiology Gifted Teacher Award and a University of Medicine and Dentistry of New Jersey 2004 Distinguished Alumnus Award. ASE’s Arthur E. Weyman Young Investigator’s Award (YIA) was created in 2007 in honor of Dr. Weyman’s unwavering commitment to research in cardiovascular ultrasound. He received ASE’s Meritorious Service Award in 2012 recognizing his contributions to the field and ASE. Dr. Weyman was also a driving force behind the creation of the National Board of Echocardiography. He served as their first president and remained on their board in an emeritus status. In his honor, the NBE has supported the ASE’s YIA award since 2007.
He completed his medical degree at New Jersey College of Medicine in 1966 and proceeded to his first residency at St. Vincent’s Hospital in New York. He then put his residency on hold while he served in the U.S. Navy as a Marine squadron and air group flight surgeon from 1968-1971. Upon returning, he completed a second year and chief residency at St. Vincent’s, followed by a three-year cardiology fellowship at Indiana University, where he was a fellow in training under ASE’s Founder Dr. Harvey Feigenbaum. In 1980, Dr. Weyman moved to Massachusetts General Hospital and Harvard Medical School in Boston, MA, where he spent the rest of his illustrious career before retiring in 2022. Named Mass General’s chief of cardiology in 1994, his development of innovative methods, research models and exemplary mentoring led the way for echocardiography to become the go-to assessment tool for heart and vascular imaging. He built the echocardiography laboratory into a powerhouse for research, education, and clinical productivity. Known as “the mentor of mentors,” Dr. Weyman and the Mass General echo lab became the place where countless physicians and sonographers competed for fellowships to train in his lab and learn to be great echocardiographers and leaders including seven ASE Presidents.
As one of the founding leaders in echocardiography, he advocated tirelessly for international recognition of the pivotal role the noninvasive assessment tool plays in saving lives by quickly detecting cardiac issues in patients from infants to adults. His presence at the helm of ASE and NBE changed the field forever. He will be missed and we are forever grateful for his service.
A devoted family man, Weyman leaves behind his wife, Jean, their four children and grandchildren.
Listen to a 2009 interview with Dr. Weyman on ASE’s YouTube channel.
A funeral Mass for Dr. Weyman will be held in St. Paul Church, 502 Washington St., Wellesley on Saturday, June 22, at 10AM. Relatives and friends kindly invited. The Mass will also be live streamed at www.harborview.live. Interment in Woodlawn Cemetery, Wellesley.
ASE 2024 Research Spotlight 4
FOR IMMEDIATE RELEASE
Contact: Angie Porter
919-297-7152
APorter@ASEcho.org
Echocardiography Plays an Important Role in Identifying Risk of Future Hypertension in Preeclampsia Patients
(DURHAM, NC, June 14, 2024)—Research that will be presented at the American Society of Echocardiography’s 35th Annual Scientific Sessions, June 14-16, 2024, in Portland, Oregon, will share how echocardiography can be used to help predict the future development of hypertension in women who had preeclampsia during pregnancy.
Preeclampsia, a condition characterized by high blood pressure and organ damage during pregnancy, affects numerous women worldwide. After giving birth, some women who experienced preeclampsia are at an increased risk of developing hypertension. However, accurately identifying those at risk can be challenging, and there is currently limited research on how echocardiographic changes influence outcomes.
The research study, titled “Echocardiographic Parameters Associated with Future Hypertension in Patients with Preeclampsia,” intended to address that knowledge gap by utilizing echocardiography performed in the first three months post-preeclampsia to identify specific findings that could indicate an increased risk of high blood pressure in the future.
Researchers retrospectively examined echocardiographic predictors, such as left ventricular mass index (LVMi) and increased interventricular septal thickness (IVSD), as parameters for future diagnosis of hypertension. Out of the 252 women included in the study, which was conducted at Allegheny Health Network in Pittsburgh, Penn., nearly 50 percent were subsequently diagnosed with hypertension during follow-up within 2.3 years.
“Our study used echocardiography to check for specific findings that could identify women who might be at higher risk for high blood pressure after preeclampsia,” said lead author Dr. Anushree Puttur, a resident physician at the Allegheny Health Network. “By finding these clues, we hope to improve how we monitor and care for women after they’ve had preeclampsia.”
ASE 2024 will feature more than 450 abstract presentations showcasing cutting-edge research on the latest advances in cardiovascular ultrasound and cases illustrating breakthroughs in patient care. This research study will be presented as a rapid-fire abstract presentation on Saturday, June 15, from 4:00 to 5:00 p.m. at the Oregon Convention Center. Learn more about ASE 2024 and download the conference’s final event program at ASEScientificSessions.org.
About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information visit ASE’s website ASEcho.org or social media pages on Facebook, X (formerly Twitter), LinkedIn, or Instagram.
###